Hypotonia, Weakness, and Stroke




Muscle Weakness and Hypotonia


(See Nelson Textbook of Pediatrics, p. 3397.)


Hypotonia, or abnormally diminished muscle tone, is defined as decreased resistance to passive movement of a limb through its range of motion. Hypotonia affects children of all ages and may be acute or chronic, progressive or static, isolated or part of a complex clinical situation, and may or may not be associated with weakness. The evaluation of children with hypotonia can be simplified by a thoughtful, analytic approach to the differential clues that are useful in identifying an underlying cause starting with detailed general and neurologic examinations ( Table 29.1 and Fig. 29.1 ). Localizing the lesion based on examination in conjunction with laboratory, genetic, and imaging studies is key to arriving at a diagnosis ( Table 29.2 ).



TABLE 29.1

Causes of Hypotonia and Weakness














































Systemic Connective Tissue Cerebral Spinal Cord Anterior Horn Cell Peripheral Nerve Neuromuscular Junction Muscle
Common



  • Sepsis



  • Heart failure



  • Acidosis



  • Hypoxia



  • Renal failure



  • Hypoglycemia



  • Down syndrome



  • Prader–Willi syndrome



  • Fragile X syndrome



  • Hypothyroidism



  • Other chromosomal disorders



  • Maternal-fetal drug effects




  • Stickler syndrome



  • Marfan syndrome



  • Achondroplasia




  • Hypoxic-ischemic brain injury



  • Intracranial hemorrhage



  • Brain malformation *



  • Intrauterine infection



  • Postnatal brain injury




  • Myelodysplasia



  • Spinal cord tumor



  • Epidural abscess



  • Transverse myelitis



  • Trauma (transection or compression)



  • Syringomyelia




  • Spinal muscular atrophy




  • Postinfectious polyneuropathy (Guillain–Barré syndrome)



  • Toxic neuropathies (isoniazid, vincristine, platinum-based antineoplastic medications, nitrofurantoin)




  • Botulism



  • Infantile myasthenia



  • Transient acquired neonatal myasthenia




  • Duchenne muscular dystrophy



  • Becker muscular dystrophy



  • Myotonic dystrophy



  • Dermatomyositis

Uncommon



  • Disorders of amino acid metabolism



  • Urea cycle disorders



  • Peroxisomal disorders



  • Scurvy



  • Rickets



  • Sotos syndrome



  • Angelman syndrome



  • Rett syndrome



  • Smith–Lemli–Opitz syndrome




  • Ehlers–Danlos syndrome



  • Osteogenesis imperfecta



  • Velocardiofacial syndrome




  • Progressive encephalopathies



  • Mitochondrial disease




  • Neonatal spinal cord transection



  • Hypoxic-ischemic myelopathy



  • Arteriovenous malformation




  • Möbius syndrome




  • Chronic inflammatory demyelinating polyneuropathy



  • Charcot–Marie–Tooth disease



  • Hereditary sensory and autonomic neuropathies




  • Toxic (organophosphate poisoning, aminoglycosides, magnesium)



  • Postneuromuscular blocking agents (vecuronium)




  • Pompe disease

Rare



  • Lowe syndrome



  • Zellweger syndrome



  • Neonatal adrenoleukodystrophy



  • Mucolipidosis type IV



  • Tay–Sachs disease



  • Gangliosidosis



  • Mannosidosis



  • Infantile neuroaxonal dystrophy




  • Miller–Dieker syndrome



  • Congenital muscular dystrophy



  • Metachromatic leukodystrophy



  • Krabbe disease




  • Poliomyelitis



  • Incontinentia pigmenti



  • Fazio–Londe disease



  • Brown–Vialetto–Van Laere syndrome




  • Refsum disease



  • Giant axonal neuropathy



  • Metachromatic leukodystrophy



  • Krabbe disease




  • Congenital myasthenic syndromes




  • Other muscular dystrophies



  • Congenital myopathies



  • Metabolic myopathies



  • Mitochondrial myopathies


* Examples of brain malformations include agenesis of the corpus callosum, lissencephaly, Joubert syndrome, and Dandy-Walker malformations.




FIGURE 29.1


Approach to the hypotonic newborn. abnl, abnormal; CHF, congestive heart failure; CNS, central nervous system; CK, creatine kinase; CT, computed tomography; EMG, electromyography; HIE, hypoxic-ischemic encephalopathy; MRI, magnetic resonance imaging; DM1, myotonic dystrophy type 1; nl, normal; sx, signs.


TABLE 29.2

Differentiating the Causes of Infantile Hypotonia































































































































































Localization Cause History and Exam Findings Investigation to Aid in Diagnosis
Central nervous system HIE
Intracerebral hemorrhage
Prematurity, difficult delivery Brain MRI
Brain malformations Cranial nerve abnormalities, Babinski sign, gradual development of hypertonia (especially axial), respiratory or feeding difficulties, global delay Cerebral ultrasound
Brain MRI
Intrauterine infection Fever, altered mental status Microbial cultures/evaluations, CSF evaluation
Postnatal birth injury Seizures, focal neurologic deficits Brain MRI, EEG
Progressive encephalopathies (leukodystrophies, progressive myoclonic epilepsies, Lennox–Gastaut syndrome, infantile spasms) Seizures, developmental regression, ataxia, focal neurologic deficits, visual loss Brain MRI, EEG, EMG/NCS (useful in adrenoleukodystrophy, Krabbe disease and metachromatic leukodystrophy), specific genetic testing
Mitochondrial disease Seizures, focal neurologic deficits, global delay, visual loss, hyper- or hyporeflexia Brain MRI, muscle biopsy, mitochondrial DNA sequencing and deletion on muscle or affected tissue, elevated lactic acid, elevated CK, EMG/NCS
Spinal cord


  • Spinal cord tumor



  • Syringomyelia



  • HIE



  • Trauma



  • AVM

Spinal level on exam, weakness below a defined spinal level, absent reflexes (acutely) or hyperreflexia (chronically) below the level, may have Babinski sign, history of trauma Brain MRI, complete spinal MRI
Anterior horn cell Spinal muscular atrophy Absence of antigravity movements, tongue fasciculations, absent reflexes to hyporeflexia, normal cognition, breathing/feeding difficulties; weakness in legs more than arms in SMA types II–III SMN deletion analysis
Poliomyelitis Neck stiffness, muscle spasms, areflexia, asymmetric flaccid paralysis of a limb, respiratory distress, muscle atrophy, normal sensation Isolate poliovirus from stool, confirm using RT-PCR or genomic sequencing, acute and convalescent serology showing 4-fold increase in titer, EMG/NCS showing pure motor neuronopathy
Incontinentia pigmenti Skin blistering, wartlike skin lesions, hyperpigmented streaks, pale/hairless atrophic linear streaks that respect Blaschko lines, dental abnormalities, intellectual delay DNA analysis, EMG/NCS showing pure motor neuronopathy
Fazio-Londe disease
Brown–Vialetto–Van Laere syndrome (BVVL)
Bulbar palsy, facial weakness, hearing loss (BVVL only), respiratory compromise, muscle weakness DNA analysis
Peripheral nerve Guillain–Barré syndrome (GBS)
Chronic inflammatory demyelinating polyneuropathy (CIDP)
Sensory ataxia with walking difficulties, rapidly (GBS) or slowly (CIDP) progressive weakness, absent reflexes or hyporeflexia, autonomic dysfunction, antecedent gastrointestinal/respiratory illness in GBS EMG/NCS with absent or prolonged F-waves, prolonged distal latencies, conduction block, demyelinating nerve conduction velocities, CSF showing cytoalbuminologic dissociation, MRI with edematous enhancing nerve roots
Toxic neuropathies History and temporal correlation with exposure to a neurotoxic drug, distal then proximal muscle weakness, absent reflexes or hyporeflexia, sensory ataxia with walking difficulties EMG/NCS showing mixed axonal/demyelinating features, plasma drug levels
Charcot–Marie–Tooth disease Family history of similar disease, pes cavus and hammer toe foot deformities, ataxic gait, foot drop, absent reflexes or hyporeflexia EMG/NCS to determine if axonal or demyelinating subtypes, DNA analysis
Hereditary sensory and autonomic neuropathies Sensory loss in a stocking/glove distribution, chronic skin ulceration and poor wound healing, distal muscle weakness with foot deformity, absent reflexes or hyporeflexia, variable anhidrosis EMG/NCS showing normal or mildly abnormal motor responses and abnormal sensory responses, nerve biopsy showing reduced myelinated and unmyelinated fibers, DNA analysis
Refsum disease Autosomal recessive inheritance, stocking/glove distribution of sensory and motor weakness, anosmia, hearing loss, ataxia, ichthyosis, short metacarpals and metatarsals, cardiac arrhythmia, and cardiomyopathy Elevated plasma phytanic acid concentration, DNA analysis
Giant axonal neuropathy Stocking/glove distribution of sensory loss and motor weakness, cerebellar ataxia, absent reflexes or hyporeflexia, kinky hair (tightly curled), nystagmus, dysarthria, pyramidal tract signs, optic neuropathy, seizures Brain MRI with white matter abnormalities, axonal sensorimotor polyneuropathy on EMG/NCS, nerve biopsy showing giant axons (axonal swelling) and disorganized neurofilaments, DNA analysis



  • Metachromatic leukodystrophy



  • Krabbe disease



  • Adrenoleukodystrophy

Developmental regression, absent reflexes or hyporeflexia, Babinski signs EMG/NCS showing demyelinating neuropathy, brain MRI showing white matter disease, DNA analysis
Neuromuscular junction Botulism Sudden poor feeding, constipation, weak cry, gradual muscle weakness, dilated poorly reactive pupils, exposure to soil/dust with bacterium or honey consumption Presence of toxin in stool/serum, culture bacterium from stool, EMG/NCS showing low-amplitude motor responses or decrement on repetitive nerve stimulation in a weak muscle
Transient acquired neonatal myasthenia Ptosis, feeding and respiratory difficulties, aspiration, mother with signs or symptoms of autoimmune myasthenia Maternal history of myasthenia, EMG/NCS showing decrement on repetitive nerve stimulation in a weak muscle, good response to acetylcholinesterase inhibitors
Infantile (autoimmune) myasthenia Ptosis, episodic weakness, recurrent feeding and respiratory difficulties, easy fatigability EMG/NCS showing decrement on repetitive nerve stimulation in a weak muscle, good response to acetylcholinesterase inhibitors, antiacetylcholine receptor antibody serology
Congenital myasthenic syndrome Ptosis, episodic weakness, recurrent feeding and respiratory difficulties, easy fatigability EMG/NCS showing decrement on repetitive nerve stimulation in a weak muscle, DNA analysis, negative anti-acetylcholine receptor antibody serology
Muscle Duchenne/Becker muscular dystrophy X-linked recessive pattern of inheritance, enlarged calves, proximal muscle weakness with a Gower maneuver Markedly elevated CK, DNA analysis
Congenital myotonic dystrophy Autosomal dominant pattern of inheritance, frog-leg position, open down-turned mouth, minimal antigravity movements in infants, distal > proximal weakness in children, impaired relaxation of grip, dysarthria, myopathic facies with temporal wasting Test mother (then father) for clinical myotonia or electrical myotonic discharges, EMG/NCS with myopathy in newborn period and myotonic discharges in older children, normal to mildly elevated CK, DPMK gene CTG repeat analysis
Dermatomyositis Subacute proximal muscle weakness, rash (Gottron papules, heliotrope rash), cutaneous calcinosis Normal to mildly elevated CK, muscle biopsy showing perimysial and perivascular inflammation, and MAC deposition on microvasculature
Pompe disease Absence of antigravity movements, severe cardiomegaly, feeding/respiratory difficulties, hepatomegaly GAA enzyme activity in dried blood spot, lymphocytes or fibroblasts, GAA gene analysis to confirm
Congenital muscular dystrophy Family history, proximal > distal muscle weakness, feeding and respiratory difficulties, early-onset contractures in specific subtypes, keloids/hyperkeratosis pilaris in specific subtypes, CNS dysfunction in specific subtypes Brain MRI, mild to markedly elevated CK, muscle biopsy showing dystrophic changes, muscle MRI, EMG/NCS to assess for demyelinating neuropathy component and myopathy, DNA analysis
Congenital myopathies Family history, proximal > distal muscle weakness, feeding and respiratory difficulties, ptosis and ophthalmoparesis in specific subtypes Normal to mildly elevated CK, muscle biopsy showing specific changes (nemaline rods, cores, centrally-placed nuclei), DNA analysis
Metabolic myopathies Family history, proximal muscle weakness, history of rhabdomyolysis or myoglobinuria, 2nd-wind phenomenon in some subtypes Normal to markedly elevated CK, EMG/NCS usually myopathic, muscle biopsy, DNA analysis
Mitochondrial myopathies Maternal inheritance pattern, proximal > distal weakness, ptosis, ophthalmoparesis, short stature, variable cardiac and CNS involvement, recurrent rhabdomyolysis Normal to moderately elevated CK, EMG/NCS showing myopathy and variable neuropathy, muscle biopsy with ragged red fibers, mitochondrial DNA analysis

AVM, arteriovenous malformation; CK, creatine kinase; CNS, central nervous system; CSF, cerebrospinal fluid; CTG, cytosine-thymine-guanine; GAA, α-glucosidase; HIE, hypoxic-ischemic encephalopathy; EEG, electroencephalogram; EMG/NCS, electromyography/nerve conduction study; GI, gastrointestinal; MAC, membrane attack complex; MRI, magnetic resonance imaging; RT-PCR, reverse transcription polymerase chain reaction; SMA, spinal motor atrophy.

Modified from Sparks SE. Neonatal hypotonia. Clin Perinatol . 2015;42:363-371.


The assessment of muscle tone can be made by several observations, including:




  • Evaluation of spontaneous posture



  • Extent of mobility of joints



  • Response to flapping of distal extremities



  • Response to postural changes



The method of evaluating muscle tone and strength depends on the age of the patient.


Muscle tone is defined as the resistance experienced by the examiner to movement of limbs about joints. Muscle tone is divided into postural and phasic. Postural tone is that experienced by the steady flexion or extension of a joint and is caused by the resultant uniform resistance of muscle to passive movement. Antigravity posture of muscle is caused by postural tone. Phasic tone is the catch experienced when an extremity is rapidly flexed or extended. The anatomic structures responsible for muscle tone are contained in a closed circuit formed by the muscle spindle, which is connected to the spinal cord by sensory afferent pathways. The sensory afferent fibers synapse directly or indirectly with anterior horn α and γ motor neurons. The α motor neurons end at the neuromuscular junction (NMJ), and the γ motor neurons end at the muscle spindle, completing the closed circuit ( Fig. 29.2 ). It is the level of activity of the γ motor neurons and its influence on the muscle spindle that sets the level of resting muscle tone. This lower motor neuron pathway is closely monitored and influenced by descending pathways from the cerebral cortex, basal ganglia, brainstem, and cerebellum. These descending pathways constitute the upper motor neuron pathways that influence resting muscle tone.




FIGURE 29.2


Lower motor neuron pathway influencing resting muscle tone. Stretching of the quadriceps muscle (agonist) will result in relaxation or inhibition of the hamstring muscle (antagonist).


The maintenance of normal muscle tone requires the integrity of the entire central and peripheral nervous systems from the cerebral cortex, cortical white matter pathways, basal ganglia, cerebellum, brainstem, spinal cord, peripheral nerve, NMJ, and muscle. Diseases that affect the function of the nervous system at any level may result in abnormal muscle tone ( Table 29.3 ; see Table 29.2 ). Broadly categorizing hypotonia into central versus peripheral nervous system causes based on history and examination is a useful initial diagnostic step ( Table 29.4 ). An estimated 80-90% of infantile hypotonia is central in origin, with the remaining 10-20% being peripheral.



TABLE 29.3

Localization of Symptoms to Neural Axis







































































































UPPER MOTOR UNIT LOWER MOTOR UNIT
Brain Spinal Cord Alpha Motor Neuron Peripheral Nerve Neuromuscular Junction Muscle
Level of consciousness Normal Normal Normal Normal Normal
Strength Mild to moderate ↓ Mild to moderate ↓ Marked ↓ Marked ↓ Marked ↓ Marked ↓
Tone Spastic (hypotonia at onset possible) ↓Acutely; ↑ ↓, flaccid
DTR Normal to ↑ ↓Acutely; ↑ ↓ to absent ↓ to absent (lost early) Normal Normal to ↓ to absent
Babinski Present Present usually Absent Absent Absent Absent
Fasciculations Absent Absent Present Rarely Absent Absent
Atrophy Mild to moderate Mild to moderate Present Present Absent Present
Pseudohypertrophy
Sensation Normal Absent below level of lesion Normal Abnormal in defined peripheral nerve distribution or glove/stocking Normal Normal
CK Normal Normal Normal to moderately elevated (several 1000s IU/L) Normal or mildly elevated (100s IU/L) Normal Normal to severely elevated
Overall pattern Hemibody deficits Spinal level present Proximal weakness in SMA; asymmetric weakness in other diseases Distal, length-dependent usually, defined nerve territory Symmetric, painless weakness of tonically active muscles Proximal > distal weakness
Other


  • Seizures



  • Developmental delay



  • Regression



  • Cortical signs (e.g., language)

Radicular back pain, bowel/bladder dysfunction Fluctuating diurnal variation Myalgia, Gower sign

CK, creatine kinase; DTR, deep tendon reflexes; SMA, spinal muscular atrophy.


TABLE 29.4

Exam and Historical Findings to Distinguish Central from Peripheral Hypotonia
































































Finding Central Peripheral
Seizures Present Absent
Altered mental status Present Absent
Delayed cognitive milestones Present Absent
Deep tendon reflexes Normal or increased Absent or decreased usually
Babinski sign Present Absent
Infantile reflexes Persistent Not persistent
Pull-to-sit Minor head lag Marked head lag
Tongue fasciculations without other cranial nerve deficits Unlikely Very likely
Ophthalmoparesis Present in brainstem disease Present in some myopathic diseases
Ptosis Present in some brainstem diseases Present in some myopathic and neuromuscular junction diseases
Weakness Mild to moderate Severe
Antigravity movements Present Absent usually
Arthrogryposis Less common More common
Muscle atrophy None to mild Moderate to severe


Most cases of acute lateralized body weakness result from abnormalities of the blood supply to a portion of the central nervous system (CNS). Stroke serves as a term to denote the sudden onset of symptoms attributable to such an interruption of cerebral or spinal perfusion. The clinical presentations and causes of stroke are best considered with respect to each of three age groups: neonates, children between 1 and 13 years of age, and adolescents, and are discussed later in this chapter.




Hypotonic Infant


Clinical Evaluation


In an infant, historical information must include a complete obstetric history as well as accurate data about perinatal events, diet, toxic exposure, and family diseases. The muscle strength, passive tone, joint extensibility, and postural reflexes including responses to traction, axillary suspension, and ventral suspension of the hypotonic infant should be compared to that of the normal infant ( Fig. 29.3 ).




FIGURE 29.3


Normal postural responses in a 5-month-old infant showing that the elbow does not extend beyond the midline on joint extensibility testing (A), the head and body in the same plane (no head lag) on pull-to-sit with resistance resulting in flexed elbows and knees (B), and lack of a slip-through feeling with resistance against the examiner’s hands, good maintenance of head control, and extension of the head and legs with the steppage reflex (D). An infant with hypoxic-ischemic encephalopathy who was initially hypotonic at the time of delivery was noted to be hypertonic at 8 months with a normal ventral suspension response as evidenced by the ability to keep the head above horizontal (C).


Muscle Strength


Muscle strength cannot be measured directly in infants ( Table 29.5 ), but numerous clinical clues allow the careful observer to identify weakness. The most important of these is the spontaneous posture. The weak infant has diminished or no spontaneous movement, often in striking contrast to the usual vigorous and plentiful movements of the infant with normal strength. The lower extremities are abducted, and the lateral surfaces of the thighs lie against the examination table, whereas the upper extremities lie extended alongside the body or flexed in a flaccid position beside the head ( Figs. 29.4 and 29.5 A ). With marked weakness, there are no movements that overcome the pull of gravity. The immobility of the weak infant results in flattening of the occipital bone, which is often associated with occipital hair loss. When placed in a sitting posture, the infant droops forward, the shoulders droop, the head falls forward, and the arms hang limply.



TABLE 29.5

Grading Muscle Strength








  • 0: No contraction



  • 1: Minimal contraction only



  • 2: Moves in horizontal plane but not against gravity



  • 3: Moves against gravity but not against resistance



  • 4: Moves against gravity and minimal resistance



  • 5: Moves against gravity and full resistance




FIGURE 29.4


Spinal muscular atrophy I (Werdnig-Hoffman disease): characteristic postures. A, A 6-week-old infant with severe weakness and hypotonia from birth. Note the frog-leg posture of the lower limbs and internal rotation (“jug-handle”) at the shoulders. B, A 1-year-old infant with frog-leg posture, external rotation at shoulders, intercostal recession, and normal facial expressions. A 6-week old infant with marked weakness of the limbs and trunk giving the characteristic inverted “U” appearance on ventral suspension (C) and pull-to-sit (D).

(Modified from Volpe JJ, ed. Neurology of the Newborn . 5th ed. Philadelphia: Saunders; 2008:770-771.)



FIGURE 29.5


An 18-month-old infant, with an undiagnosed pure motor neuron disorder with severe axial more than appendicular weakness, delays in motor milestones, and respiratory insufficiency, has internal rotation of upper arm and frog-leg position (A), a slip-through appearance on axillary suspension (B), and a prominent head lag on pull-to-sit traction testing (C).


Passive Tone


Passive tone can be assessed by evaluating the resistance to movement of the limbs through a range of motion at the joints. Evaluation of the shoulders, elbows, wrists, hips, knees, and ankles is especially helpful. The examiner senses a “looseness” of the limbs as the limbs are moved.


In addition, grasping the midportion of the infant’s limb and passively flapping the extremity allow the examiner to evaluate the degree of limpness of the distal extremity. In the hypotonic infant, the hands and feet wave limply; in the normal infant, the ankle and wrist are maintained fairly rigidly in line with the rest of the extremity.


Even in normal infants, there is a wide variation of muscle tone. Passive muscle tone varies and is particularly diminished after feeding and before sleep. There is profound hypotonia in all infants during sleep. Tone can also be affected by the position of the head. The child whose head is turned to one side may be manifesting an asymmetric tonic neck response , with increased extensor tone on the side of the body to which the head is turned and increased flexor tone on the contralateral side. This asymmetry of tone may be elicited even in the child who does not exhibit the typical “fencer’s” posture ( Fig. 29.6 ). Therefore, examination of an infant should always be conducted while the infant’s head is at the midline; the same is true for eliciting muscle stretch reflexes. Hypotonia can also be associated with heart failure, sepsis, acidosis, failure to thrive, and other systemic conditions (see Table 29.1 ).




FIGURE 29.6


Asymmetric tonic neck reflex. Normally present from birth to 2 months. Turning head to 1 side when supine elicits extension of arms and leg ipsilateral to side that head is turned and flexion of opposite arm and leg. Persistence beyond 2 months might suggest abnormal development of contralateral motor cortex.


Joint Extensibility


The extent to which the joints may be extensible provides an indirect clue to the presence of hypotonia. Examination of mobility at the elbows, wrists, hips, and knees is helpful. The hypotonic infant may assume unusual postures in the presence of joint hyperextensibility. The “scarf sign” is a useful sign of hyperextensibility in the young infant. With the infant in a semireclining position, the hand is pulled across the chest toward the opposite shoulder and the position of the elbow is noted (see Fig. 29.3 A ). If the elbow passes the midline, then there is hypotonia.


Postural Reflexes


Traction response (pull-to-sit).


The traction response is the most useful and most sensitive of the postural reflexes in infants. With the infant lying supine, the infant’s hands are grasped, and the infant is pulled up to a sitting position. Once the sitting posture is attained, the head is held erect in the midline. During the maneuver, the examiner notes the infant’s attempt to counter the traction by flexion of the arms (see Fig. 29.3 B ).


In an infant younger than 3 months, the plantar grasp should also be evident. In addition, there should be flexion at the elbow, knee, and ankle in response to the maneuver. The degree to which the head and neck pull up along with the trunk depends on the child’s age.


In infants younger than 33 weeks’ gestation, there is no traction response. From 33 weeks to term, the infant has head lag but responds to the traction maneuver by flexing the neck flexors in an attempt to lift the head. The full-term infant exhibits a traction response with minimal head lag, and when the sitting posture is attained, the head may be held erect momentarily and then falls forward.


By age 3 months, there should be no head lag, and the head should be aligned with the plane of the back as the child is pulled to sitting. The absence of flexion of the limbs in response to the examiner’s pull and the presence of head lag inappropriate for age suggests hypotonia (see Figs. 29.4 D and 29.5 C ).


Axillary suspension.


The response to axillary suspension allows assessment of generalized and shoulder girdle tone. The infant is held under the arms, lifted, and suspended from the axillae without the thorax being grasped. In infants with normal tone and strength, the shoulder girdle muscles exert enough strength to allow the infant to be suspended without slipping through the examiner’s grasp. In addition, the infant’s head is held midline and the legs are held with some flexion at the hips, knees, and ankles (see Fig. 29.3 D ). The hypotonic infant droops with legs extended and head falling forward, and the absence of resistance of the muscles of the shoulder girdle allows the infant to slip through the grasp of the examiner as the baby’s arms fling upward (see Fig. 29.5 B ).


Ventral suspension.


The response to ventral suspension allows assessment of tone of the trunk, neck, and extremities. The examiner holds the infant, who is lying prone. The infant is supported only by the examiner’s hand on the abdomen. A normal infant holds the head erect and the back straight and holds the extremities with some flexion at the elbows, hips, knees, and ankles (see Fig. 29.3 C ). A full-term neonate makes intermittent attempts to hold the head straight, maintains the back straight, and can flex the limbs. The hypotonic infant droops in the examiner’s palm, as if in the shape of an inverted “U,” with the head and legs dangling limply (see Fig. 29.4 C ).


Diagnostic Approach


A careful perinatal history is obtained to identify possible features suggestive of perinatal hypoxic-ischemic brain injury . The infant who has a neurologic dysfunction attributable to perinatal asphyxia should have demonstrated evidence of an acute encephalopathy during the neonatal period (disturbance of consciousness, poor feeding, seizures, autonomic dysfunction).


A computed tomographic (CT) study or magnetic resonance imaging (MRI) of the head is helpful to identify evidence of brain malformation, intrauterine infection, hypoxic brain injury, intracranial hemorrhage, or hydrocephalus. If the history suggests seizures, an electroencephalogram (EEG) should be obtained.


An ophthalmologic evaluation may detect evidence of ocular malformation (cataracts, microphthalmia, optic hypoplasia), evidence of intrauterine infection (chorioretinitis), or retinal/macular abnormality (retinitis pigmentosa, cherry-red spot) (see Chapter 32 ).


In some cases, requesting a hearing evaluation or brainstem auditory evoked response may be appropriate. A lumbar puncture is necessary only if acute or chronic (intrauterine) meningitis is suspected.


Fig. 29.1 summarizes the approach to the hypotonic newborn. After a thorough history and careful physical examination, it should be determined whether the infant has signs of encephalopathy. A CT scan or MRI of the head is obtained to detect any anatomic abnormalities. If the scan does not reveal an abnormality and if the neonate exhibits increased reflexes and tone over time, a diagnosis of static encephalopathy can be made. If hypotonia persists, anterior horn cell disease, congenital myopathy, or NMJ disease should be considered (see Tables 29.1 and 29.3 ).


If the baby is not encephalopathic, the practitioner should determine whether a syndrome (Prader–Willi or Down) is present. Is the motor-sensory level consistent with myelodysplasia or spinal cord injury? In addition, causes of arthrogryposis multiplex congenita must be considered ( Table 29.6 ).



TABLE 29.6

Major Causes of Arthrogryposis Multiplex Congenita































Site of Major Pathologic Findings Disorder
Cerebrum, brainstem, cerebellum


  • Microcephaly



  • Cortical migrational disorders: lissencephaly-pachygyria (e.g., Zellweger syndrome), polymicrogyria, agenesis of the corpus callosum, schizencephaly



  • Pontocerebellar hypoplasia (type 1)



  • Dentato-olivary dysplasia



  • Cytomegalovirus infection



  • Leptomeningeal angiomatosis



  • Encephaloclastic processes: porencephalies, hydranencephaly, multicystic encephalomalacia



  • Hydrocephalus

Spinal cord


  • Cervical spinal atrophy



  • Lumbosacral meningomyelocele



  • Sacral agenesis

Anterior horn cell


  • Spinal muscular atrophy type 1



  • Spinal muscular atrophy with respiratory distress type 1

Peripheral nerve


  • Charcot–Marie–Tooth disease

Neuromuscular junction


  • Congenital myasthenic syndromes



  • Maternal autoimmune myasthenia (rare)

Muscle


  • Congenital myotonic dystrophy



  • Congenital muscular dystrophies



  • Congenital myopathies (nemaline myopathy, myotubular myopathy, core myopathy)



  • Distal arthrogryposis syndromes (types 1–10)

Intrauterine/maternal factors


  • Amyoplasia (vascular compromise to fetus or placenta during embryogenesis)



  • Lack of space: multiple pregnancies, uterine abnormality (bicornuate uterus, uterine fibroid)



  • Fetal alcohol syndrome with contractures



  • Intrauterine tumors



  • Amniotic fluid leakage



  • Disruption (bands)



  • Maternal illnesses: infections, untreated SLE, metabolic imbalances



  • Maternal medications (curare, muscle relaxants)



  • Maternal injuries in the 1st trimester

Joint and connective tissue abnormalities


  • Chondrodysplasia



  • Congenital contractural arachnodactyly



  • Marfan syndrome


SLE, systemic lupus erythematosus.

Modified from Volpe JJ, ed. Neurology of the Newborn . 5th ed. Philadelphia: Saunders; 2008:760.


If the baby is markedly weak, the examiner should check to see whether the mother is also weak (proximal muscle weakness, ptosis, ophthalmoparesis) or whether she displays myotonia (on hand grip or to percussion). If either is true, then transplacental-derived transient neonatal myasthenia gravis or myotonic dystrophy , respectively, is a possibility ( Table 29.7 ). If neither is the case, then myopathy ( Table 29.8 ) , congenital (genetic) myasthenia, infant botulism ( Table 29.9 ) , or anterior horn cell disease must be considered (see Table 29.2 ).



TABLE 29.7

Clinical Features of Congenital Myotonic Dystrophy























































Clinical Feature % of Cases Exhibiting Feature
Hypotonia 100
Muscle atrophy 100
Transmission via mother 100
Intellectual disability in survivors 100
Facial diplegia 100
Feeding difficulties 92
Respiratory distress 88
Hyporeflexia or areflexia 87
Arthrogryposis 82
Polyhydramnios 80
Reduced fetal movements 68
Edema 54
Premature birth (<36 wk) 52
Elevated right hemidiaphragm 49
Neonatal mortality 41
Infant death in siblings 28

(See Nelson Textbook of Pediatrics, p. 2980.)

From Volpe JJ, ed. Neurology of the Newborn . 5th ed. Philadelphia: Saunders; 2008:802.


TABLE 29.8

Specific Congenital Myopathies: Distinguishing Clinical Features
























Subcategory Distinguishing Clinical Features Associated Genes:
Central core disease


  • Facial weakness mostly with RYR1



  • Ophthalmoparesis and ptosis with RYR1



  • High incidence of malignant hyperthermia with RYR1



  • Severe axial/respiratory weakness out of proportion to limb weakness with SEPN1



  • Prominent early fixed kyphoscoliosis with RYR1



  • Rigid spine in older childhood with SEPN1



  • High incidence of club feet, pes cavus, foot drop, and distal hand/foot muscle atrophy with RYR1

RYR1, SEPN1, TTN, MYH7, CCDC78
Nemaline myopathy


  • Prominent facial weakness



  • Severe bulbar weakness, feeding difficulties, and respiratory compromise in neonatal period or early infancy in some

ACTA1, NEB, TPM3, TPM2, TNNT1, CFL2, KBTBD13, KLHL40, KLHL41, LMOD3
Centronuclear myopathy


  • Prominent facial weakness



  • Prominent ophthalmoparesis and ptosis (in infancy)



  • Prominent bilateral ptosis



  • Severe bulbar weakness, feeding difficulties, and respiratory compromise in neonatal period or early infancy



  • Infant that is long for age with elongated hands/feet



  • High incidence of neonatal/infantile death with MTM1



  • High incidence of club feet, pes cavus, foot drop, and distal hand/foot muscle atrophy with DMN2

MTM1 (causes myotubular myopathy), DNM2, BIN1, RYR1
Congenital fiber type disproportion


  • Severe axial/respiratory weakness out of proportion to limb with SEPN1



  • Rigid spine in older childhood with SEPN1

TPM3, RYR1, TPM2, SEPN1, ACTA1

RYR1 , ryanodine receptor 1; SEPN1 , selenoprotein N 1; TTN , titin; MYH7 , myosin heavy chain 7; CCDC78 , coiled-coil domain-containing protein 78; ACTA1 , alpha-actin-1; NEB , nebulin; TPM3 , tropomyosin 3; TPM2 , tropomyosin 2; TNNT1 , troponin T1; CFL2 , cofilin 2; KBTBD13 , Kelch repeat and BTB/POZ domains-containing protein 13; KLHL40 , Kelch-like 40; KLHL41 , Kelch-like 41; MTM1 , myotubularin; DNM2 , dynamin 2; BIN1 , bridging integrator 1; LMOD3 , leiomodin 3.


TABLE 29.9

Infantile Botulism Versus “Congenital Myasthenia” *












































Infantile Botulism “Congenital Myasthenia”
Sudden onset in a previously healthy infant +
Generalized hypotonia and weakness + +
Facial weakness, ptosis + +
Dilated, poorly reactive pupils +
Constipation +
Response to anticholinesterases +
3 Hz (low frequency) RNS^ Decremental response Decremental response
High-frequency RNS^ Incremental response in mild cases Decremental response
Family history +/−

Modified from Volpe JJ, ed. Neurology of the Newborn . 5th ed. Philadelphia: Saunders; 2008:791.

* Congenital myasthenia includes congenital myasthenic syndromes, infantile (autoimmune) myasthenia, and transient acquired neonatal myasthenia; +, present; −, absent; +/−, variable; RNS^, repetitive nerve stimulation.



Common Disorders


Hypoxic-ischemic encephalopathy.


Brain injury resulting from asphyxia, hypoxia, or ischemia is an important cause of neonatal neurologic morbidity. Tissue oxygen deficiency is presumed to underlie the neurologic injury caused by hypoxic-ischemic insults. An oxygen deficit may be incurred by either hypoxemia or ischemia. Hypoxemia is defined as diminished oxygen content of blood. Ischemia is characterized by reduced blood perfusion in a particular tissue bed. Hypoxemia and ischemia often occur simultaneously or in sequence. Ischemia is likely to be the more important of these 2 insults.


Asphyxia denotes an impairment in gas exchange, which results not only in a deficit of oxygen in blood but also in an excess of carbon dioxide and thereby acidosis. Furthermore, sustained asphyxia usually results in hypotension and ischemia, which is consistent with the likely predominant importance of ischemia as the final common pathway to brain injury. Asphyxia is the most common clinical insult resulting in brain injury during the perinatal period.


Evidence of hypoxic-ischemic injury to the neonatal nervous system is reflected by a constellation of signs noticed early after birth. The asphyxiating event or events may occur at any point in the antepartum, intrapartum, or postpartum periods. On the basis of admittedly imprecise historical data, it has been concluded that insults sustained by the fetus during the antepartum period account for approximately 20% of cases of hypoxic-ischemic encephalopathy (HIE). Maternal cardiac arrest or hemorrhage leading to transplacental and fetal hypotension represents such prenatal insults. Intrapartum events, such as placental abruption, uterine rupture, and traumatic delivery, may account for 35% of cases of HIE. In an additional 35% of infants displaying signs of HIE, markers of intrapartum fetal distress and antepartum risk, such as maternal diabetes, intrauterine growth restriction, or maternal infection, are found. Postpartum difficulties, such as cardiovascular compromise, persistent fetal circulation, and recurrent apnea, account for approximately 10% of HIE cases. Postpartum difficulties are found more commonly in premature than in full-term infants. Therefore, for at least 65% of cases of neonatal HIE, difficulties of the intrapartum period alone do not explain the encephalopathy.


Recognition of neonatal HIE requires careful observation and examination of the newborn in the context of a detailed history of pregnancy, labor, and delivery. Newborns who have sustained hypoxic-ischemic insults severe enough to cause permanent neurologic injury usually demonstrate abnormalities on neurologic examination. Indeed, a combination of low Apgar scores, fetal acidosis or distress, and abnormal neurologic examination findings help define HIE. Nonetheless, if the hypoxic-ischemic damage has occurred well in advance of parturition, it may be asymptomatic in the neonate.


Mild HIE (stage 1) may be characterized by hyperalertness or by mild depression of the level of consciousness, which may be accompanied by uninhibited Moro and brisk deep tendon reflexes, signs of sympathetic activity (dilated pupils), and a normal or only slightly abnormal EEG. Typically, these symptoms last less than 24 hours. Moderate HIE (stage 2) may be marked by obtundation, hypotonia, diminished number of spontaneous movements, and seizures. Infants with severe HIE (stage 3) are ill for more than 24 hours and are comatose. In addition, they are markedly hypotonic and display bulbar and autonomic dysfunction. The EEG is abnormal and may demonstrate a burst-suppression pattern or seizures, or it may be isoelectric.


Neonates with moderate or severe HIE may show variation in level of consciousness during the 1st days after birth. Initially, depression of level of alertness may appear to improve after the first 12-24 hours after birth. However, specific signs of improving alertness such as visual fixation or following are lacking. In addition, other persistent or progressive neurologic deficits, as well as functional deterioration of other extraneural systems, are inconsistent with a true improvement in neurologic state. Coma may persist, supervene, or even progress to brain death by 72 hours of life. If the infant survives 72 hours without losing all cerebral function, a variable amount of improvement may be observed.


Diffuse hypotonia accompanied by a lack of movement constitutes the most frequently observed motor deficit found early in the course of neonatal HIE. By the end of the 1st day, patterns of weakness that reflect the distribution of cerebral injury from a generalized hypoxic-ischemic insult may emerge. Affected full-term infants may demonstrate quadriparesis with predominant proximal limb weakness. This pattern of weakness derives from ischemia in the watershed or parasagittal region of the brain, which corresponds to the border zones of circulation between the anterior and the middle cerebral arteries and the middle and the posterior cerebral arteries. Affected premature infants may have weakness primarily in the lower extremities because of perinatal ischemic injury of motor fibers serving the legs. These fibers lie dorsal and lateral to the external angles of the lateral ventricles. Focal injury resulting from focal ischemia (stroke) may result in focal deficits reflective of the vascular territory in which the injury has occurred. These patterns are relatively subtle. As many as 70% of infants with moderate or severe HIE experiences seizures by the end of the 1st day of life.


Focal and multifocal ischemic brain injury may occur during the perinatal period. Such injury, most often infarction, occurs in a vascular distribution. Prenatal cerebral infarctions have been identified by intrauterine ultrasonography. In one autopsy study of neonates, 32 of 592 (5%) infants had cerebral infarctions. Among neonates surviving only a few hours after birth, several had infarctions with subacute or chronic histologic characteristics, indicating that the ischemic insult occurred before parturition. Focal seizures are the heralding sign of neonatal stroke. Although clinical signs corresponding to the area of infarction are expected, they may be absent. Neonatal strokes may follow uneventful deliveries and may occur in otherwise normal-appearing infants. Stroke may also accompany asphyxia, coagulopathy, polycythemia, and sepsis. A predilection for these ischemic lesions to occur in the territory of the middle cerebral artery, especially the left, has been noted and remains unexplained.


A direct relationship between motor and cognitive deficits at 1 year of age and the severity of acidosis observed at birth in asphyxiated and symptomatic neonates has been described. The extent of these sequelae is dependent not only on the occurrence of asphyxia but also on its duration. The 3 stages of HIE also correlate with outcome at 1 year of age. Those neonates with mild (stage 1) HIE or those who demonstrate moderate (stage 2) HIE for less than 5 days usually develop normally. Persistence of moderate encephalopathy or appearance of severe (stage 3) HIE is associated with seizures and motor and cognitive delay during follow-up. Children with mild HIE as neonates tend to be free of handicap in motor, cognitive, and school performance. Greater impairment of performance in each of these developmental spheres is found among children who exhibited moderate or severe neonatal HIE.


The likelihood of long-term neurologic sequelae after HIE is increased by the presence of neonatal seizures. The EEG may provide valuable prognostic information after the occurrence of seizure. Interictal background abnormalities, such as a burst-suppression pattern, persistently low voltage, and electrocerebral inactivity, are highly correlated with poor outcome. Conversely, infants with normal EEGs or those revealing only maturational delay have much more favorable prognoses.


Neuroimaging is useful in determination of prognosis. Head ultrasonography has shown that severe periventricular intraparenchymal echodensities followed by evidence of tissue injury (cyst formation) are correlated with later motor and cognitive deficits in premature infants. MRI performed early in the neonatal course of hypoxic-ischemic brain injury provides useful prognostic information. Most infants with MRI evidence of basal ganglia “hemorrhage,” periventricular leukomalacia, or multicystic encephalomalacia after asphyxia ultimately demonstrate neurodevelopmental abnormalities. Diffusion-weighted imaging (DWI) reveals evidence of neonatal brain injury earlier than T1 and T2 weighted pulse sequences. Indeed, DWI reveals focal injury when standard MRI and CT are normal ( Fig. 29.7 ).




FIGURE 29.7


A and C, Predominant patterns of brain injury in newborns with hypoxic-ischemic brain injury. These apparent diffusion coefficient maps performed on day 3 of life and ( B and D ) T1 weighted images performed on day 10 of life are typical of the 2 major predominant patterns of brain injury seen in term newborns with hypoxic-ischemic encephalopathy. A, In the “watershed” pattern, areas of restricted diffusion are seen in the parasagittal regions (arrows). B, One week later, very subtle hyperintensities can be seen in the same areas on the T1 weighted images (arrows). C, In the “basal nuclei” predominant pattern, the areas that show restricted diffusion are the thalami and basal ganglia (white star) bilaterally. In this example, part of the optic radiation is also affected (black arrow). D, On day 10, the injury in the thalami and basal ganglia (black star) appears as T1 hyperintensities bilaterally.


Brain malformations.


Brain malformation can arise as a result of a chromosomal disorder, as a component of a multiple malformation syndrome, or as an isolated abnormality. When associated with a chromosomal disorder or multiple malformation syndromes, the other associated features are the primary clues to diagnosis. In isolated brain malformation, the primary features are microcephaly (in most cases) and cognitive and motor developmental impairment. The MRI scan can detect abnormalities of development of the hemispheric structures (agenesis of the corpus callosum, holoprosencephaly), abnormalities of cortical cellular migration (lissencephaly, pachygyria), and cerebral heterotopias as well as brainstem and cerebellar malformations (e.g., Joubert syndrome).


Uncommon Disorders


Progressive encephalopathies of infancy.


Progressive encephalopathies of infancy account for a small number of children with persistent hypotonia (see Chapter 24 ). These disorders are recognizable by a progressive deterioration of neurologic function and by diagnostically specific clues. The infant’s development is normal for some time and then plateaus; this is followed by developmental regression with loss of previously acquired skills. Hypotonia is a feature of many of these disorders, at least at some point during the course of the illness. Some disorders feature hypotonia as the result of the combination of CNS injury and an associated polyneuropathy (Krabbe disease and metachromatic leukodystrophy). Progressive disorders that may be associated with hypotonia include neonatal adrenoleukodystrophy, mannosidosis, fucosidosis, Gaucher disease types 2 and 3, GM 1 gangliosidosis, infantile neuroaxonal dystrophy, infantile Refsum disease, Krabbe disease, metachromatic leukodystrophy, mucolipidosis type IV, and Tay–Sachs disease. The diagnosis of these disorders is based on recognition of clinically suggestive clues and on results of specialized biochemical and molecular genetic testing. If such a disorder is suspected, the infant should be referred to appropriate genetic and neurologic specialists.


Mitochondrial diseases.


Mitochondrial diseases often affect both the brain and muscle and clinically manifest as hypotonia, probably as a combination of both cerebral dysfunction and myopathy ( Tables 29.10 and 29.11 ). The diagnosis is based on recognition of clinical symptoms, presence of lactic acidosis, presence of ragged red fibers on muscle histologic examination, and mitochondrial abnormalities identifiable on a muscle electron microscopic examination ( Fig. 29.8 ). The diagnosis of many mitochondrial diseases is possible by specific mitochondrial DNA testing. Other inborn errors of metabolism may produce hypotonia by central mechanisms (organic acidurias, hyperammonemia) or by interfering with muscle metabolism ( Table 29.12 ).



TABLE 29.10

Clinical Spectrum of Mitochondrial Disease



















Nervous System



  • Hypotonia



  • Failure to thrive



  • Motor regression



  • Stroke (nonvascular)



  • Dementia



  • Episodic encephalopathy (elevated cerebrospinal fluid lactate)



  • Intellectual disability



  • Neuropathy (axonal, demyelinating, or sensory ganglionopathy)



  • Ophthalmoparesis (slowly progressive)



  • Ptosis (slowly progressive; little diurnal variation; asymmetric at onset)



  • Optic atrophy



  • Retinitis pigmentosa (perimacular; vision usually spared)



  • Ataxia



  • Central apnea



  • Epilepsy (focal or multifocal myoclonus; status epilepticus; triggered by sodium valproate)



  • Migraines



  • Sensorineural hearing loss (asymmetric; young onset; partial recovery possible)

Heart



  • Cardiomyopathy



  • Conduction block or arrhythmia

Skeletal Muscle



  • Myopathy (proximal, symmetric weakness; myalgia)



  • Exercise intolerance



  • Episodic rhabdomyolysis

Other



  • Lactic acidosis



  • Recurrent bowel obstruction (pseudoobstruction)



  • Short stature



  • Diabetes (young onset; nonobese)


Modified from Amato A, Russell J. Neuromuscular Disorders. 1st ed. New York: McGraw-Hill; 2008; Liang C, Ahmad K, Sue CM. The broadening spectrum of mitochondrial disease: shifts in the diagnostic paradigm. Biochim Biophys Acta . 2014;1840:1360-1367.


TABLE 29.11

Select Mitochondrial Disorders with Hypotonia Classified by Clinical Phenotype and Genotype
























































Clinical Phenotype Associated Mutations Mode of Inheritance Common Clinical Features
MELAS syndrome (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes) tRNA point mutations:



  • m.3243A>G in tRNA Leu (~80% of cases)



  • m.3217T>C in tRNA Leu (~7.5% of cases)



  • m.13513G>A encoding NADH-ubiquinone (<15% of cases)



  • m.3252A>G in tRNA Leu (<5% of cases)



  • Multiple other mtDNA point mutations

Maternal


  • Cardinal―strokelike episodes, intermittent encephalopathy, T2/FLAIR abnormalities on brain MRI that do not respect vascular territory, lactic acidosis



  • Other―hearing loss, diabetes, short stature, gastrointestinal issues

MERRF syndrome (myoclonic epilepsy with ragged red fibers) tRNA point mutations:



  • m.8344A>G in tRNA Lys (>80% of cases)



  • m.8356T>C in tRNA Lys



  • m.8363G>A in tRNA Lys



  • m.8361G>A in tRNA Lys



  • Multiple other mtDNA point mutations

Maternal


  • Cardinal―myoclonus, proximal weakness, generalized epilepsy, ataxia



  • Other―multiple lipomatosis, hearing loss, cognitive impairment, neuropathy

KSS (Kearns–Sayre syndrome) Single large mtDNA deletion (1.1-10-kb)



  • m.8470_13446del4977 (deletion of 4977 base pairs; most common)



  • Multiple other mtDNA deletions

Sporadic


  • Cardinal―multisystemic disease with progressive external ophthalmoplegia, pigmentary retinopathy, cardiomyopathy before age 20 yr



  • Other―short stature, proximal muscle weakness, hearing loss, dementia, ataxia, multiple endocrinopathies (diabetes, hypothyroidism, hypoparathyroidism, hypogonadism

CPEO (chronic progressive external ophthalmoplegia) Single large mtDNA deletion (1.1-10 kb) Sporadic


  • Cardinal―skeletal muscle disorder with ptosis, ophthalmoparesis, +/− proximal muscle weakness




  • m.3243A>G in tRNA Leu (most common; same as MELAS)



  • Multiple other mtDNA point mutations

Maternal



  • Multiple mtDNA deletions caused by mutations in the following nuclear genes: SLC25A4 encoding ANT1, C10orf2 encoding twinkle, POLG1 encoding mtDNA polymerase, POLG2, OPA1

Autosomal dominant
Leigh syndrome (subacute necrotizing encephalomyelopathy) mtDNA mutations:



  • m.8993T>G or m.8993T>C in MT-ATP6 (~10% of cases)



  • Multiple other mtDNA point mutations

Maternal


  • Hypotonia, spasticity, movement disorders (chorea), cerebellar ataxia, neuropathy, bilateral basal ganglia lesions, seizures, lactic acidosis, psychomotor retardation/regression especially with illness between 3-12 mo of age



  • Hypertrophic cardiomyopathy




  • m.8470_13446del4977 (deletion of 4977 base pairs; also seen in KSS)

Sporadic
Nuclear gene mutations resulting in respiratory chain complex deficiencies:



  • Complex I: NDUFV1, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS7, NDUFS8, NDUFA1, NDUFA2, NDUFA10, NDUFA9, NDUFA12, NDUFAF2, NDUFAF5, NDUFAF6, FOXRED1



  • Complex II: SDHA, SDHAF1



  • Complex III: BCS1L, UQCRQ, TTC19



  • Complex IV: SURF1, COX10, COX15, SCO2, NDUFA4, PET100, LRPPRC

Autosomal recessive
NARP
(neurogenic muscle weakness, ataxia, retinitis pigmentosa)



  • m.8993T>G or m.8993T>C in MT-ATP6 (50% of cases)

Maternal


  • Proximal neurogenic muscle weakness, sensory neuropathy, seizures, ataxia, pigmentary retinopathy, learning difficulties, dementia with onset usually in childhood

Mitochondrial DNA depletion syndrome


  • Homozygous or compound heterozygous mutations in TK2 (thymidine kinase 2), a mitochondrial deoxyribonuclease, resulting in mitochondrial depletion

Autosomal recessive


  • Hypotonia, proximal muscle weakness, axial weakness, respiratory insufficiency, marked clinical variability with death in infancy to early adulthood due to respiratory insufficiency


FLAIR, fluid-attenuated inversion recovery; GI, gastrointestinal; MRI, magnetic resonance imaging; mtDNA, mitochondrial DNA; NADH, nicotinamide adenine dinucleotide, reduced form; tRNA, transfer RNA.

Data from DiMauro S, Hirano M. MERRF . 2003 Jun 3. Seattle (WA): University of Washington: GeneReviews (Internet); DiMauro S, Hirano M. MELAS . 2001 Feb 27. Seattle (WA): University of Washington: GeneReviews (Internet); Thorburn DR, Rahman S. Mitochondrial DNA-Associated Leigh Syndrome and NARP . 2003 Oct 30. Seattle (WA): University of Washington: GeneReviews (Internet); Liang C, Ahmad K, Sue CM. The broadening spectrum of mitochondrial disease: shifts in the diagnostic paradigm. Biochim Biophys Acta. 2014;1840:1360-1367.



FIGURE 29.8


Pathologic changes seen in mitochondrial myopathy. Hematoxylin and eosin stain (A) demonstrating increased fiber size variation and subsarcolemmal basophilic deposits (arrows) correlating with ragged red fibers (arrows) on Gomori trichrome (B) oil red O (C) and toluidine (D) staining showing increased lipid deposition in the fibers (arrows) indicative of marked mitochondrial dysfunction due to defects in β-oxidation. (E) COX (brown stain) with SDH counterstain (blue stain) showing many COX-negative fibers (blue staining fibers) indicative of mitochondrial dysfunction since the COX enzyme is partly encoded within mitochondrial DNA. (F) Electron microscopy showing classic paracrystalline “parking lot” inclusions within the mitochondria located immediately underneath the sarcolemma that correlate highly with mitochondrial dysfunction (arrows ; inset with higher magnification) and increased lipid deposition (arrowheads).

( A, Courtesy Michael Lawlor, MD, PhD, Medical College of Wisconsin, Milwaukee, WI; C, D, and F courtesy Karra Jones, MD, PhD, UC San Diego, San Diego, CA; B, E, courtesy Chamindra Konersman, MD, Medical College of Wisconsin, Milwaukee, WI.)


TABLE 29.12

Metabolic Diseases That Affect Muscle



































































Name(s) Enzyme Deficiency Clinical Features Diagnostic Testing
Glycogen storage disease type II (Pompe disease) α-1,4-Glucosidase (GAA enzyme)


  • Infantile-onset Pompe—poor feeding, motor delay and hypotonia with weakness, respiratory difficulties, cardiac issues (short P-R interval with wide QRS complex, cardiomegaly, LV outflow obstruction, cardiomyopathy)



  • Late-onset Pompe—limb-girdle pattern of weakness, respiratory insufficiency without clinical heart disease



  • GAA enzyme replacement therapy available




  • Measure α-glucosidase (GAA) enzyme activity on dried blood spot to screen



  • Confirm via GAA gene sequencing demonstrating biallelic mutations for definitive diagnosis



  • Baseline elevated CK (~10× normal) in infantile-onset form; baseline CK may be normal in adult-onset form



  • Muscle biopsy may show vacuoles (lysosomes) and glycogen accumulation with positively staining PAS; 20–30% of patients with adult-onset form may not show specific changes on biopsy

Glycogen storage disease type IIIa (Debrancher deficiency, Cori disease, Forbes disease) Amylo-1,6-glucosidase


  • Ketotic hypoglycemia, hepatomegaly, hyperlipidemia, elevated liver enzymes, cardiomyopathy in childhood, limb-girdle pattern of weakness in 20s–30s




  • Baseline elevated CK (2–20× normal)



  • Triglycerides, cholesterol, and liver enzymes are elevated



  • AGL gene sequencing demonstrating biallelic mutations for definitive diagnosis

Glycogen storage disease type IV (Brancher deficiency, Andersen disease) Glycogen branching enzyme (GBE)


  • Fatal perinatal neuromuscular subtype—fetal akinesia, polyhydramnios, fetal hydrops



  • Congenital neuromuscular subtype—hypotonic newborn, respiratory distress, dilated cardiomyopathy, death in infancy



  • Childhood neuromuscular subtype—chronic progressive myopathy, dilated cardiomyopathy




  • Demonstrate deficiency of GBE in the liver, muscle, or skin fibroblasts



  • GBE1 gene sequencing demonstrating biallelic mutations for definitive diagnosis

Glycogen storage disease type V (McArdle disease) Myophosphorylase


  • Exercise-induced muscle cramps and pain, especially early in exercise, that improve with rest or lower intensity (“2nd-wind phenomenon”)



  • Recurrent myoglobinuria +/− rhabdomyolysis




  • Baseline elevated CK (>5× normal)



  • PYGM gene sequencing demonstrating biallelic mutations for definitive diagnosis



  • Quantitative or qualitative (stain) on muscle biopsy shows virtual absence of enzyme activity



  • Subsarcolemmal glycogen accumulation on muscle biopsy on LM (either PAS-positive or vacuoles on H&E) and EM

Glycogen storage disease type VII
(Tarui disease)
Phosphofructokinase


  • Classical form—muscle aching, cramping, exercise intolerance, myoglobinuria, nausea/vomiting after intense exercise, starting in childhood; hemolytic anemia



  • Late-onset form—cramps, myalgia, mild proximal weakness in adulthood



  • Infantile form—hypotonia, arthrogryposis, intellectual disability, fatal in infancy




  • Baseline elevated CK



  • PFK gene sequencing demonstrating biallelic mutations for definitive diagnosis

Glycogen storage disease VIII (phosphorylase kinase [PhK] deficiency) Phosphorylase b kinase


  • Exercise intolerance, cramps, myoglobinuria, progressive muscle weakness in childhood to adulthood



  • Hepatomegaly, growth retardation, fasting ketosis and hypoglycemia




  • Baseline elevated CK



  • PhK enzyme activity reduced in muscle



  • PHKA1 gene sequencing or/and PHKB gene sequencing demonstrating biallelic mutations for definitive diagnosis

Phosphorylase a1 kinase


  • Same as above but X-linked and very rare

Glycogen storage disease IX (phosphoglycerate kinase deficiency) Phosphoglycerate kinase


  • Myopathic form—muscle weakness, pain, cramping, especially with exercise with myoglobinuria +/− rhabdomyolysis




  • Baseline mildly elevated CK



  • PGK1 gene sequencing demonstrating biallelic mutations for definitive diagnosis

Glycogen storage disease X (Phosphoglycerate mutase deficiency) Phosphoglycerate mutase


  • Strenuous exercise intolerance, cramps, myoglobinuria




  • Baseline mildly elevated CK



  • PGAM2 gene sequencing demonstrating biallelic mutations for definitive diagnosis

Glycogen storage disease XI (lactate dehydrogenase deficiency) Lactate dehydrogenase


  • Exercise intolerance, cramping, recurrent myoglobinuria




  • Normal CK between attacks



  • LDHA gene sequencing demonstrating biallelic mutations for definitive diagnosis

Systemic primary carnitine deficiency Solute carrier family 22 (sodium-dependent carnitine transporter)


  • Childhood myopathic form—hypotonia, dilated cardiomyopathy that could result in death, proximal muscle weakness in early childhood (2–4 yr)



  • Adult form—fatigability




  • Baseline CK elevated



  • Reduced plasma carnitine levels



  • Increased lipid deposition on muscle biopsy



  • SLC22A5 gene sequencing demonstrating biallelic mutations for definitive diagnosis

Carnitine palmitoyltransferase II deficiency Carnitine palmitoyltransferase II (CPT II)


  • Myopathic form—recurrent myalgia and myoglobinuria after prolonged exercise, cold, or fasting; weakness during attacks; onset from childhood to adulthood



  • Severe infantile form—liver failure, cardiomyopathy, seizures, hypoketotic hypoglycemia, myopathy before 1 yr of age (rare)




  • Normal CK between attacks



  • CPT II gene sequencing demonstrating biallelic mutations for definitive diagnosis



  • Muscle biopsy can be normal


CK, creatine kinase; EM, electron microscopy; H&E, hematoxylin and eosin; LM, light microscopy; LV, left ventricular; PAS, periodic acid–Schiff.


Brain malformation syndromes.


Miller–Dieker syndrome is characterized by severe lissencephaly (“smooth brain” with agyria), severe developmental impairment, hypotonia early in life, and hypertonia with age. The facial changes include bitemporal hollowing, upturned nares, thin vermilion border, and small jaw. Fluorescence in situ hybridization–detectable microdeletions of 17p13.3 in the PAFAH1B1 and YWHAE genes cause 80% of de novo mutations, whereas the remaining 20% are inherited from a parent with a balanced chromosomal rearrangement.


Muscle-eye-brain diseases (MEB) are an expanding category of congenital muscular dystrophies with eye abnormalities and an assortment of brain malformations including cobblestone lissencephaly type II, focal pachygyria, polymicrogyria, pontocerebellar hypoplasia, and occipital encephalocele. These diseases are characterized by hypotonia in infancy due to a concomitant muscular dystrophy and CNS disease and variable degrees of intellectual disability. Walker–Warburg syndrome is the most severe form of MEB, usually resulting with early demise. Genes associated with MEB are increasing rapidly: POMT1 , POMT2 , POMGnT1 , FKTN , FKRP , LARGE , ISPD , GTDC2 , B3GALNT2 , B3GNT1 , TMEM5 , POMK , DPM1 , DPM2 , DPM3 , DOLK , GMPPB , and DAG1.




Hypotonic Older Child


Clinical Evaluation


Posture and Strength


Observation of the child’s spontaneous posture may suggest the presence of weakness. Muscle strength can be observed as the child performs functional tasks, including pulling to sit spontaneously from a prone position, arising to stand from a sitting or lying position, standing on 1 leg independently, hopping, walking, running, and climbing stairs. The wheelbarrow maneuver can be used to functionally assess strength in the upper extremities. In the child older than 5 years, manual muscle testing can be performed if the child is cooperative (see Table 29.5 ). The examiner evaluates each muscle group independently, comparing the child’s muscle strength in resistance to the examiner’s strength. The child with muscle weakness has difficulty performing motor tasks and may exhibit unusual postures (lordosis) or toe walking, and on manual muscle testing, may be easily overcome by the examiner’s strength.


Passive Tone


Passive muscle tone is more consistent during the waking hours in the child than in the infant. The major joints should be moved through their range of motion and the extent of resistance noted. Flapping the distal extremities provides a useful clue. Briskly lifting the lower extremity at the knee while the patient lies supine is a useful test of muscle tone. In the normal child, the foot briefly drags along the examination table and then rises with the leg. In the hypertonic child, the leg remains extended stiffly at the knee. In the hypotonic child, the lower leg hangs limply and the foot drags as the knee is raised.


Joint Extensibility


The hypotonic child demonstrates hyperextensibility of joints, especially at the elbows, wrists, knees, and ankles. Examination of the small muscles of the fingers may also be helpful ( Fig. 29.9 ).




FIGURE 29.9


Hyperlaxity at the distal interphalangeal joints in a 9-year-old girl with a congenital myopathy.


Diagnostic Approach


The diagnosis of a particular neurologic disorder depends on the location of the lesion (i.e., which part of the nervous system is impaired or abnormal), the patient’s age, and whether the condition is progressive or static (see Tables 29.1 to 29.3 ). Fig. 29.10 outlines an algorithm for determining the cause of muscle weakness in a child.


Apr 4, 2019 | Posted by in PEDIATRICS | Comments Off on Hypotonia, Weakness, and Stroke

Full access? Get Clinical Tree

Get Clinical Tree app for offline access